Evidence map›Paper›PMID 33101451›Full record

ArticlePlant methods2020

Evaluating the suitability of hyper- and multispectral imaging to detect foliar symptoms of the grapevine trunk disease Esca in vineyards.

Nele Bendel, Anna Kicherer, Andreas Backhaus, Hans-Christian Klück, Udo Seiffert, Michael Fischer, Ralf T Voegele, Reinhard Töpfer

Open access · goldAbstract read
In one paragraph

Article in Plant methods, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Nele BendelInstitute for Grapevine Breeding, Julius Kühn-Institut, Federal Research Centre for Cultivated Plants, Geilweilerhof, 76833 Siebeldingen, Germany.
Anna KichererInstitute for Grapevine Breeding, Julius Kühn-Institut, Federal Research Centre for Cultivated Plants, Geilweilerhof, 76833 Siebeldingen, Germany.ORCID 0000-0002-6442-3219
Andreas BackhausBiosystems Engineering, Fraunhofer Institute for Factory Operation and Automation (IFF), Sandtorstr. 22, 39106 Magdeburg, Germany.
Hans-Christian KlückBiosystems Engineering, Fraunhofer Institute for Factory Operation and Automation (IFF), Sandtorstr. 22, 39106 Magdeburg, Germany.
Udo SeiffertBiosystems Engineering, Fraunhofer Institute for Factory Operation and Automation (IFF), Sandtorstr. 22, 39106 Magdeburg, Germany.
Michael FischerInstitute for Plant Protection in Fruit Crops and Viticulture, Julius Kühn-Institut, Federal Research Centre for Cultivated Plants, Geilweilerhof, 76833 Siebeldingen, Germany.
Ralf T VoegeleInstitute of Phytomedicine, University of Hohenheim, Otto-Sander-Straße 5, 70599 Stuttgart, Germany.
Reinhard TöpferInstitute for Grapevine Breeding, Julius Kühn-Institut, Federal Research Centre for Cultivated Plants, Geilweilerhof, 76833 Siebeldingen, Germany.
Fraunhofer Institute for Factory Operation and Automation · DEJulius Kühn-Institut · DEUniversity of Hohenheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGrapevine trunk diseases (GTDs) such as Esca are among the most devastating threats to viticulture. Due to the lack of efficient preventive and curative treatments, Esca causes severe economic losses worldwide. Since symptoms do not develop consecutively, the true incidence of the disease in a vineyard is difficult to assess. Therefore, an annual monitoring is required. In this context, automatic detection of symptoms could be a great relief for winegrowers. Spectral sensors have proven to be successful in disease detection, allowing a non-destructive, objective, and fast data acquisition. The aim of this study is to evaluate the feasibility of the in-field detection of foliar Esca symptoms over three consecutive years using ground-based hyperspectral and airborne multispectral imaging.

resultsHyperspectral disease detection models have been successfully developed using either original field data or manually annotated data. In a next step, these models were applied on plant scale. While the model using annotated data performed better during development, the model using original data showed higher classification accuracies when applied in practical work. Moreover, the transferability of disease detection models to unknown data was tested. Although the visible and near-infrared (VNIR) range showed promising results, the transfer of such models is challenging. Initial results indicate that external symptoms could be detected pre-symptomatically, but this needs further evaluation. Furthermore, an application specific multispectral approach was simulated by identifying the most important wavelengths for the differentiation tasks, which was then compared to real multispectral data. Even though the ground-based multispectral disease detection was successful, airborne detection remains difficult.

conclusionsIn this study, ground-based hyperspectral and airborne multispectral approaches for the detection of foliar Esca symptoms are presented. Both sensor systems seem to be suitable for the in-field detection of the disease, even though airborne data acquisition has to be further optimized. Our disease detection approaches could facilitate monitoring plant phenotypes in a vineyard.

Indexed as

Disease detectionGrapevine trunk diseasePhenolinerPhenotyping platformPlant phenotypingPrecision viticultureSpectral imaging

Identifiers

PMID33101451
PMCPMC7579826
OpenAlexW3093652956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.